Serum price tumbles as Jump Trading takes FTX Estate to court over SRM token loan

The value of Serum (SRM) has dropped by nearly 8% as Jump Trading’s subsidiary, Tai Mo Shan, and the FTX bankruptcy estate engage in a legal battle over an unresolved loan agreement involving 800 million SRM tokens. Tai Mo Shan is seeking $264 million in damages from the FTX estate, claiming that Alameda Research, a former trading partner of FTX, failed to deliver the agreed-upon SRM tokens. The loan was meant to support Serum, a decentralized exchange (DEX) backed by FTX. With FTX’s collapse, the loan was never fulfilled, leading to the legal dispute. The FTX estate, however, argues that the loan agreement was never executed since the SRM tokens were never delivered. They also raise concerns about the possibility of fraudulent transfers. This ongoing legal battle has caused uncertainty in the market, resulting in a significant drop in the price of SRM. The outcome of this case could have significant implications for the future of Serum’s native token, SRM.